AstraZeneca gets £3 billion valuation boost following global vaccine withdrawal

AstraZeneca has witnessed a significant increase in its market valuation, adding more than £3 billion as it announced the global withdrawal of its COVID-19 vaccine. The company’s shares rose by 1.6 percent, contributing to a new record high for the FTSE 100. Withdrawal driven by commercial reasons The Anglo-Swedish...